Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 23.16 -0.28 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.44 | 52 Week High | $12.48 | |||
| Open | $23.33 | 52 Week Low | $1.60 | |||
| Day High | $23.56 | P/E | N/A | |||
| Day Low | $22.88 | EPS | $-6.33 | |||
| Volume | 389,565 | |||||

